under

NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES / ISSUANCE OF A NEW SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM

Ghent, Belgium, March 26, 2026 (GLOBE NEWSWIRE) -- PRESS RELEASE REGULATED INFORMATION - INSIDE INFORMATION26 March 2026, 8:00 pm CET…

1 month ago

Zevra Therapeutics Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)

March 20, 2026 16:30 ET  | Source: Zevra Therapeutics BOSTON, March 20, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS:…

2 months ago

Le Clarence Awarded Two Michelin Stars Under the Direction of Andrea Capasso

PARIS, March 17, 2026 /PRNewswire/ -- Le Clarence, an essential address of Parisian haute gastronomy, celebrates its two stars in…

2 months ago

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PRINCETON, N.J., March 06, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and…

2 months ago

Thinkrr.ai Advances Its Voice AI Strategy Under CMO Cody Getchell Amid Growing Demand for AI-Driven Automation

Thinkrr.ai Logo WHITE ROCK, British Columbia, March 07, 2026 (GLOBE NEWSWIRE) -- Thinkrr.ai, a leading voice AI platform, announces Cody…

2 months ago

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 06, 2026 17:33 ET  | Source: Tango Therapeutics Sub, Inc BOSTON, March 06, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics,…

2 months ago

HONOR Calls for Open Collaboration Under New AI Ecosystem Vision, While New Opportunities are Coming to AI Devices

To build a truly unified interface, the company is excited to execute its open AI device ecosystem strategy through the…

2 months ago

Global governance seminar held in Geneva, marking launch of English edition of Volume I of “China’s Governance under Xi Jinping’s Leadership”

GENEVA, Feb. 27, 2026 /PRNewswire/ -- This is a report from Xinhua News Agency:  A seminar on global governance and…

2 months ago

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or “the Company”), a clinical stage…

3 months ago

HCW Biologics Announces Pricing of $1.5 Million Follow-On OfferingPriced At-The-Market Under NASDAQ Rules

MIRAMAR, Fla., Feb. 17, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company”), (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company…

3 months ago